New Investor Telegraph Article Highlighting $KETA With mental health issues rapidly growing due to the pandemic, people need solutions. I just read an article highlighting $KETA’s (TripSitter) technology and revolutionary idea to safely utilize ketamine treatments from the safety of your own home.
- Medically prescribed ketamine offers relief to severe symptoms of depression and anxiety, including vitally reducing life-threatening thoughts and suicidal behaviours.
- Many of those struggling are unaware of ketamine as a viable choice to alleviate their struggles or live too far away to access clinics for ketamine infusion.
- $KETA connects the practitioner and the patient through their proprietary platform and allows diagnosed individuals to receive monitored ketamine treatment from home.
- “$KETA provides full accessibility to anyone with internet access throughout 15 states, with the full nationwide service planned for implementation within the next 90 days.” And with additional plans to branch out to other psychedelics as regulations continue to change.
https://investortelegraph.com/meet-the-new-revolutionary-service-tripsitter/3024
As the article highlighted, $KETA is tapping into a huge unmet market with very few competitors. They've already established a strong foundation, and now it's all about scaling the business and customer acquisition. Now, looking at the stock, they have a very low market cap of $9.7M and have exited its downtrend. We could be seeing the bottom here, so this could start to see some upwards movement soon.